| P2093 | author name string | M. A. Ondetti | |
| | Petrillo EW Jr | |
| | E. W. Petrillo | |
| P2860 | cites work | Journal of Pharmacology and Experimental Therapeutics | Q1500272 |
| | pharmacologist | Q2114605 |
| | A dipeptidyl carboxypeptidase that converts angiotensin I and inactivates bradykinin | Q24300463 |
| | Structure of carboxypeptidase B at 2-8 A resolution | Q27757006 |
| | Metal-coordinating substrate analogs as inhibitors of metalloenzymes | Q33986513 |
| | Design of potent competitive inhibitors of angiotensin-converting enzyme. Carboxyalkanoyl and mercaptoalkanoyl amino acids | Q34089278 |
| | Binding of the by-product analog benzylsuccinic acid by carboxypeptidase A | Q34217732 |
| | A new class of angiotensin-converting enzyme inhibitors | Q34251984 |
| | Synthesis and biological activity of a ketomethylene analog of a tripeptide inhibitor of angiotensin converting enzyme | Q34252110 |
| | Crystallographic study of the binding of dipeptide inhibitors to thermolysin: implications for the mechanism of catalysis | Q34376750 |
| | An angiotensin converting-enzyme inhibitor to identify and treat vasoconstrictor and volume factors in hypertensive patients | Q34698738 |
| | Design of Specific Inhibitors of Angiotensin-Converting Enzyme: New Class of Orally Active Antihypertensive Agents | Q34936463 |
| | Angiotensin-Converting Enzyme and the Regulation of Vasoactive Peptides | Q37116751 |
| | Renin-angiotensin system: biochemistry and mechanisms of action | Q37382695 |
| | New Substrates for the Radioassay of Angiotensin Converting Enzyme of Endothelial Cells in Culture | Q39224457 |
| | A specific orally active inhibitor of angiotensin-converting enzyme in man. | Q39429288 |
| | Design of potent reversible inhibitors for thermolysin. Peptides containing zinc coordinating ligands and their use in affinity chromatography | Q39687412 |
| | Inhibitors of angiotensin-converting enzyme for treatment of hypertension | Q40121097 |
| | Functional residues at the active site of angiotensin converting enzyme | Q40176791 |
| | Effects of N-Mercaptoacylamino Acids on Inhibition of Angiotensin I Converting Enzyme | Q40212097 |
| | Effects of captopril in animal models of hypertension | Q40292890 |
| | Captopril: a preliminary review of its pharmacological properties and therapeutic efficacy | Q40300185 |
| | Design of potent and specific inhibitors of carboxypeptidases A and B | Q41482450 |
| | Inhibition of thermolysin and carboxypeptidase A by phosphoramidates | Q41725271 |
| | Effect of a new angiotensin converting enzyme inhibitor MK 421 and its lysine analogue on the components of the renin system in healthy subjects | Q42098372 |
| | Inhibition of angiotensin converting enzyme with Nα-phosphoryl-L-alanyl-L-proline and Nα-phosphoryl-L-valyl-L-tryptophan | Q42244920 |
| | Antihypertensive Effects of the Novel Converting-Enzyme Inhibitor YS 980 in Spontaneously Hypertensive Rats | Q42244973 |
| | Synthesis and angiotensin-converting enzyme inhibitory activity of 3-(mercaptomethyl)-2-oxo-1-pyrrolidineacetic acids and 3-(mercaptomethyl)-2-oxo-1-piperidineacetic acids | Q42244984 |
| | New sulfhydryl compounds with potent antihypertensive activities | Q46606977 |
| | Evidence for prejunctional inhibition of norepinephrine release by captopril in spontaneously hypertensive rats | Q67275996 |
| | Studies on inhibitory effect of phosphoramidon and its analogs on thermolysin | Q67348084 |
| | Peptide hydroxamic acids as inhibitors of thermolysin | Q67375686 |
| | Peptide-gap inhibitors: I. Competitive inhibition of aminopeptidase M by a hydrolytically resistant dipeptide analogue of glycylleucine | Q67546884 |
| | A crystallographic study of the complex of phosphoramidon with thermolysin. A model for the presumed catalytic transition state and for the binding of extended substances | Q67686744 |
| | Spectrophotometric assay and properties of the angiotensin-converting enzyme of rabbit lung | Q68669025 |
| | Use of first-dose response or plasma renin activity to predict the long-term effect of captopril: identification of triphasic pattern of blood pressure response | Q72612331 |
| | Reduction of pressor effects of angiotensin I in man by synthetic nonapeptide (B.P.P. 9a or SQ 20,881) which inhibits converting enzyme | Q93731616 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | pharmacology | Q128406 |
| | molecular medicine | Q3523816 |
| P304 | page(s) | 1-41 | |
| P577 | publication date | 1982-01-01 | |
| P1433 | published in | Medicinal Research Reviews | Q2436033 |
| P1476 | title | Angiotensin-converting enzyme inhibitors: medicinal chemistry and biological actions | |
| | Angiotensin-converting enzyme inhibitors: Medicinal chemistry and biological actions | |
| P478 | volume | 2 | |